Phage display-derived peptides for osteosarcoma imaging

Clinical Cancer Research

Volumn 16, Issue 16, 2010, Pages 4268-4277

  Sun, Xilin ^a,b   Niu, Gang ^a   Yan, Yongjun ^a   Yang, Min ^a,c   Chen, Kai ^a   Ma, Ying ^a   Chan, Nicholas ^a   Shen, Baozhong ^b   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c JIANGSU INSTITUTE OF NUCLEAR MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLSERYLGLYCYLALANYLLEUCYLSERYLPROLYLSERYLARGINYLLEUCYLASPARTYLTHREONINE; FLUORESCENT DYE; FLUORINE 18; PEPTIDE; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOPANNING; CANCER DIAGNOSIS; CELL LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG DISTRIBUTION; DRUG SYNTHESIS; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOLECULAR PROBE; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PHAGE DISPLAY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCREENING; SEQUENCE HOMOLOGY; STAINING;

ANIMALS; BONE NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MICE; MICE, NUDE; OSTEOSARCOMA; PEPTIDE LIBRARY; PEPTIDES;

EID: 77955737036     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-0968     Document Type: Article

References (18)

1. Lamoureux F, Trichet V, Chipoy C, Blanchard F, Gouin F, Redini F. Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies. Expert Rev Anticancer Ther 2007;7:169-81.
2. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007;110:2119-52.
3. Scotlandi K, Picci P, Kovar H. Targeted therapies in bone sarcomas. Curr Cancer Drug Targets 2009;9:843-53.
4. Kuhelj D, Jereb B. Pediatric osteosarcoma: a 35-year experience in Slovenia. Pediatr Hematol Oncol 2005;22:335-43.
5. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-80.
6. Seung-Min L, Gil-Suk Y, Eun-Sang Y, Tae-Gyun K, In-San K, Byung-Heon L. Application of phage display to discovery of tumor-specific homing peptides: developing strategies for therapy and molecular imaging of cancer. Methods Mol Biol 2009;512:355-63.
7. Jayanna PK, Bedi D, Deinnocentes P, Bird RC, Petrenko VA. Landscape phage ligands for PC3 prostate carcinoma cells. Protein Eng Des Sel 2010;23:423-30.
8. Enback J, Laakkonen P. Tumour-homing peptides: tools for targeting, imaging and destruction. Biochem Soc Trans 2007;35:780-3.
9. 3 expression. Front Biosci 2009;14:887-99.
10. Niu G, Chen X. PET imaging of angiogenesis. PET Clin 2009;4:17-38.
11. Guide for the care and use of laboratory animals. Washington (DC): National Academy Press; 1996.
12. Kelly KA, Waterman P, Weissleder R. In vivo imaging of molecularly targeted phage. Neoplasia 2006;8:1011-8.
13. 3 integrin expression. Mol Imaging Biol. Epub 2009 Dec 1.
14. 68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging. Eur J Nucl Med Mol Imaging 2009;36:1483-94.
15. Bratkovic T. Progress in phage display: evolution of the technique and its application. Cell Mol Life Sci ;67:749-67.
16. Sanderson RD, Yang Y, Kelly T, MacLeod V, Dai Y, Theus A. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. J Cell Biochem 2005;96:897-905.
17. Sasisekharan R, Moses MA, Nugent MA, Cooney CL, Langer R. Heparinase inhibits neovascularization. Proc Natl Acad Sci U S A 1994;91:1524-8.
18. Lamoureux F, Picarda G, Garrigue-Antar L, et al. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. Cancer Res 2009;69:526-36.